kathryn e. mccollister, phd · 2 days ago · kathryn e. mccollister, phd 1 university of miami...

Kathryn E. McCollister, PhD 1

UNIVERSITY OF MIAMI Curriculum Vitae

1. Date: February 9, 2020

I. PERSONAL

2. Name: Kathryn E. McCollister, Ph.D.

3. Office Phone: (305) 243−3479

4. Address: 1120 NW 14th Street, Suite 1019, Miami FL 33136

5. Current Academic Rank: Associate Professor

6. Current Track of Appointment Award of Tenure: June 1, 2013

6a. Primary Department: Public Health Sciences, School of Medicine

7. Secondary/Joint Appointments: Health Sector Management and Policy, Miami Business School

II. HIGHER EDUCATION

8. Institutional

Florida International University, Miami, FL Ph.D. Economics 1999

Florida International University, Miami, FL M.A. Economics 1997

The George Washington University, Washington, DC B.A. International Affairs 1993

9. Non−Institutional: N/A

10. Certification, licensure: N/A

III. EXPERIENCE

11. Academic Positions

Associate Professor (awarded tenure in 2013) 2013 −Present University of Miami Miller School of Medicine Department of Public Health Sciences

Assistant Professor tenure−earning track 2007 to 2013 University of Miami Miller School of Medicine Department of Epidemiology and Public Health

Research Assistant Professor 1999 to 2006 University of Miami Miller School of Medicine

Kathryn E. McCollister Ph.D.

2

Department of Epidemiology and Public Health

Senior Research Associate 1998 to 1999

University of Miami Miller School of Medicine Health Services Research Center

Instructor 1997 to 1999 Florida International University Department of Economics

Teaching Associate 1995 to 1997 Florida International University Department of Economics

12. Hospital Appointments: N/A

13. Non−Academic Positions: N/A

14. Military: N/A


3

IV. PUBLICATIONS

15. Books and monographs published:

a. McCollister, K.E., Muennig, P., Davila, E., Lee, D.J., LeBlanc, W., Fleming, L.E., Caban−Martinez, A., Ocasio, M., Clarke, T., Arheart, K., and Sestito, J. “Health−Adjusted Life Years and Burden of Disease by NORA Sectors: The National Health Interview Survey (NHIS) 1986−1996.” Monograph available at Study Website: www.umiamiorg.com

b. Fleming, L.E., Pitman, T., LeBlanc, W.G., Lee, D.J., Caban−Martinez, A.J., Arheart, K.L., McCollister, K.E., and Chung Bridges, K. “Interactive Monograph of Occupation and Health Disparities in the National Health Interview Survey (1997−2004).” 2007. Monograph available at Study Website: www.rsmas.miami.edu/groups/niehs/niosh/

c. Zhang, S., Roberts, R., and McCollister, K. E. “Final Report on the Cost Benefit Analysis of the Substance Abuse Program at the California Substance Abuse Treatment Facility and State Prison at Corcoran.” San Diego, CA: San Diego State University, 2006.

d. McCollister, K.E., and M.T. French. “The Economic Cost of Substance Abuse Treatment in Criminal Justice Settings.” In C.G. Leukefeld, F. Tims, and D. Farabee (Eds.), Treatment of Drug Offenders: Policies and Issues, New York: Springer Publishing Company, 2−37, 2002.

e. McCollister, K.E. and Rosenberg, B.N. “Cost Effectiveness of Rehabilitation Versus Incarceration.” In R. Morgan (Ed.), The SAGE Encyclopedia of Criminal Psychology (Vol. 1, pp. 219-222). Thousand Oaks, CA: SAGE Publications, Inc., 2019.

16. Juried or refereed journal articles or exhibitions: (* Authors listed alphabetically)

(§ Based on dissertation work. Authors are typically listed alphabetically in economics journals)

a. Jalali, A., Ryan, D., McCollister, K.E., Marsch, L., Schackman, B.R., and Murphy, S.M. “Economic Evaluation in the National Drug Abuse Treatment Clinical Trials Network: Past, Present, and Future.” In Press at the Journal of Substance Abuse Treatment.

b. Zheng, D.D., Christ, S.L., Feaster, D.J., McCollister, K.E., Lam, B.L., and Lee, D.J. Patterns of Chronic Conditions and Their Association with Visual Impairment and Healthcare Utilization - Application of Latent Class Analysis. In Press, JAMA Ophthalmology.

c. Reckers-Droog, V.T., Goorden, M., Dijkgraaf, M.G.W., Van Eeren, H.V., McCollister, K.E., Hakkaart-van Roijen, L. “Unit Costs of Delinquent Acts for Use in Economic Evaluations.” The Journal of Mental Health Policy and Economics, 22: 71-79, 2019.

d. Bowser, D., Henry, B. F., & McCollister, K. E. “An Overlapping Systems Conceptual Framework to Evaluate Implementation of a Behavioral Health Intervention for Justice– Involved Youth.” Health Services Insights, 2019.

e. Murphy S.M., McCollister K.E., Leff JA, Yang X, Jeng PJ, Lee JD, Nunes EV, Novo P, Rotrosen J, Schackman BR. “Cost-Effectiveness of Extended-Release Naltrexone versus

http://www.umiamiorg.com/http://www.rsmas.miami.edu/groups/niehs/niosh/


4

Buprenorphine-Naloxone to Prevent Opioid Relapse among Individuals Initiating Treatment In an Inpatient Detoxification Setting.” Annals of Internal Medicine, 2018.

f. McCollister, K.E., Yang, X., Murphy, S.M., Leff, J.A., Kronmal, R.A., Crane, H.M., Chandler, R.K., Taxman, F.S., Feaster, D.J., Metsch, L., Cunningham, W.E., Altice, F.L., Schackman, B.R. “Criminal Justice Measures for Economic Data Harmonization in Substance Use Disorder Research.” Health and Justice, 6(1), 2018.

g. McCollister, K.E., Leff, J.A., Yang, X., Lee, J.D., Nunes, E.V., Novo, P., Rotrosen, J., Schackman, B.R., Murphy, S.M. (In Press). Cost of Pharmacotherapy for Opioid Use Disorders Following Inpatient Detoxification.” American Journal of Managed Care, 24(11): 526-531, 2018.

h. Peterson, C., Kearns, M.C., McIntosh, W.L., Estefan, L.F., Nicolaidis, C., McCollister, K.E., Nygren, P., Gordon, A., Florence, C. “Lifetime Economic Burden of Intimate Partner Violence Among United States Adults.” American Journal of Preventive Medicine.55(4): 433-444, 2018.

i. McCollister, K.E., Baumer, P., Davis, M., Greene, A., Stevens, S., and Dennis, M.L. “Economic Evaluation of the Juvenile Drug Court Reclaiming Futures Model.” Journal of Behavioral Health Services and Research, 45 (3), 321-339, 2018.

j. Becan JE, Bartkowski JP, Knight DK, Wiley TRA, DiClemente R, Ducharme L, Welsh WN, Bowser D, McCollister KE, Hiller M, Spaulding AC, Flynn PM, Swartzendruber A,

Dickson MF, Fisher JH, Aarons GA. “A Model for Rigorously Applying the Exploration, Preparation, Implementation, Sustainment Framework in the Design and Measurement of a Large Scale Collaborative Multi-Site Study.” Health and Justice, 6:9, 2018.

k. Murphy, S.M., Leff, J.A., Linas, B.P., Morgan, J.R., McCollister, K.E., Schackman, B.R. “Implementation of a nationwide health economics consultation service to assist substance use researchers: Lessons learned.” Substance Abuse Journal, Mar 20, 1-19, 2018.

l. McCollister, K.E., Yang, X., Sayed, B., French, M.T., Leff, J.A., Schackman, B.R. “Monetary Conversion Factors for Economic Evaluations of Substance Use Disorders.” Journal of Substance Abuse Treatment, 81, 25-34, 2017.

m. Hartzler, B., Lyon, A.R., Walker, D.D., Matthews, L., King, K.M., McCollister, K.E. “Implementing the Teen Marijuana Check-Up In Schools.” Implementation Science, Aug 10;12(1): 103, 2017.

n. Prendergast, M., McCollister, K.E., and Warda, Umme. “A Randomized Study of the Use of Screening, Brief Intervention, and Referral to Treatment (SBIRT) with Jail Inmates.” Journal of Substance Abuse Treatment, Mar; Vol 74: 54-64, 2017.

o. Farabee, D., Hillhouse, M., Condon, T., McCrady, B., McCollister, K.E., Ling, W. “Injectable Pharmacotherapy for Opioid Use Disordr (IPOD).” Contemporary Clinical Trials, Jul; 49:70-7, 2016.

p. Chandler, R.K., Finger, M.S., Farabee, D., Schwartz, R.P., Condon, T., Dunlap, L.J., Zarkin, G.A., McCollister, K, McDonald, R.D., Laska, E., Bennett, D., Kelly, S.M., Hillhouse, M., Mitchell, S.G., O’Grady, K.E., Lee, J.D. “The


5

SOMATICS Collaborative: Introduction to a National Institute on Drug Abuse Cooperative Study of


6

Pharmacotherapy for Opioid Treatment in Criminal Justice Settings.” Contemporary Clinical Trials, May; 48:166-72, 2016.

q. McCollister, K.E., Yang, X., and McKay, J. “Cost-Effectiveness Analysis of a Continuing Care Intervention for Patients with Cocaine Dependence.” Drug and Alcohol Dependence, 158: 38-44, 2016.

r. Moon, C.S., Nanji, A.A., Galor, A., McCollister, K.E., and Karp, C.L. “Surgical Versus Medical Treatment of Ocular Surface Squamous Neoplasia: A Comparison of Costs.” Ophthalmology, 123(3): 497-504, 2016.

s. McCollister, K.E., Tolbert, D.V., Mishra, S., Natale, R., and Messiah, S.E. “Cost Analysis of a Childcare Center-Based Intervention to Prevent Obesity in the Preschool Years.” Journal of Comprehensive Pediatrics May; 6(2): e25845, 2015.

t. Fernandez, C.A., Christ, S.L., LeBlanc, W.G., Arheart, K.L., Dietz, N. A., McCollister, K.E., Fleming, L.E., Muntaner, C., Muennig, P., and Lee, D.J. “Effect of Childhood Victimization on Future Occupational Prestige and Income Trajectories.” PLOS One, 10(2), 2015.

u. McCollister, K.E., Scott, C.K., Dennis, M.L., Freitas, D.M., French, M.T., and Funk, R. “Economic Costs of a Post−Release Intervention for Incarcerated Female Substance Abusers: Recovery Management Checkups for Women Offenders (RMCWO).” Journal of Offender Rehabilitation, 53(7): 543-561, 2014.

v. Tolbert, D.V., McCollister, K.E., LeBlanc, W.G., Lee, D.J., Fleming, L.E., and Muennig,

P. “The Economic Burden of Disease by Industry: Differences in Quality‐adjusted Life Years and Associated Costs.” American Journal of Industrial Medicine, 57(7), 757-763, 2014.

w. McCollister, K.E., Freitas, D., Prado, G., and Pantin, H. “Opportunity Cost and Financial Incentives for Participation in a Family−based HIV and Substance Use Preventive Intervention for Hispanic Youth.” Journal of Primary Prevention, 35(1): 13-20, 2014.

x. McCollister, K.E., French, M.T., Freitas, D., Dennis, M.L., Scott, C.K., and Funk, R.

“Cost−effectiveness Analysis of Recovery Management Checkups (RMC) for Adults with Chronic Substance Use Disorders: Evidence from a Four-year Randomized Trial.” Addiction, 108(12): 2166-74, 2013.

y. Galor, A., Zheng, D.D., Arheart, K.L., Lam, B.L., McCollister, K.E., Ocasio, M.A., Fernandez, C.A., and Lee, D.J. “Influence of Socio−Demographic Characteristics on Eye Care Expenditure: Data from the Medical Expenditure Panel Survey 2007.” Ophthalmic Epidemiology, Early Online 1-6, 2013.

z. Prado, G., Cordova, D., Huang, S., Estrada, Y., Rosen, A., Bacio, G.A., Jimenez, G.L., Pantin, H., Brown, C.H., Velazquez, M.R., Villamar, J., Freitas, D., Tapia, M.I., and McCollister, K.E. “The Efficacy of Familias Unidas on Drug and Alcohol Outcomes for Hispanic Delinquent Youth: Main Effects and Effects by Environmental Context.” Drug and Alcohol Dependence, 125, S1: S18−S25, 2012.

aa. McCollister, K.E., Zheng, D.D., Fernandez, C., Lee, D.J., Lam, B.L., Arheart, K.L., Galor, A., Ocasio, M., and Muennig, P. “Racial Disparities in Quality−Adjusted Life Years (QALYs) Associated with Diabetes and Visual Impairment.” Diabetes Care, 35: 1692−1694, 2012.


7

bb. Galor, A., Zheng, D.D., Arheart, K.L., Lam, B.L., Perez, V.L., McCollister, K.E., Ocasio, M., McClure, L.A., and Lee, D.J. “Dry Eye Medication Use and Expenditures: Data from the Medical Expenditure Panel Survey 2001−2006.” Cornea 1−5, 2012.

cc. Caban−Martinez, A.J., Davila, E.P., Lam, B.L., Arheart, K.L., McCollister, K.E., Fernandez, C. A., Ocasio, M.A., and Lee, D.J. “Sociodemographic Correlates of Eye Care Provider Visits in the 2006−2009 Behavioral Risk Factor Surveillance Survey.” BMC Research Notes 5: 253, 2012.

dd. *Alexandre, P.K., Beulaygue, I., French, M.T., McCollister, K.E., Popovici, I., and Sayed, B.A. “The Economic Cost of Substance Abuse Treatment in the State of Florida.” Evaluation Review 36(3): 167−185, 2012.

ee. Arheart, K.L., Fleming, L.E., Lee, D.J., Leblanc, W.G., Caban−Martinez, A.J., Ocasio, M.A., McCollister, K.E., Christ, S.L., Clarke, T., Kachan, D., Davila, E.P., and Fernandez, C.A. “Occupational vs. Industry Sector Classification of the U.S. Workforce: Which Approach is More Strongly Associated with Worker Health Outcomes?” American Journal of Industrial Medicine, 54(10):748−757, 2011.

ff. Lam, B.L., Zheng, D., Davila, E.P., Arheart, K.L., Ocasio, M.A., McCollister, K.E., Caban−Martinez, A.J., and Lee, D.J. “Trends in Glaucoma Medication Expenditure: Medical Expenditure Panel Survey: 2001−2006.” Archives of Ophthalmology, 129(10): 1345−50, 2011.

gg. Dy, C.J., McCollister, K.E., Lubarsky, D.A., and Lane, J.M. “An Economic Evaluation of a Systems−Based Strategy to Expedite Surgical Repair of Hip Fractures.” Journal of Bone and Joint Surgery, 93(14): 1326−34, 2011.

hh. *Dennis, M.L., French, M.T., McCollister, K.E., and Scott, C.K. “The Economic Costs of Quarterly Monitoring and Recovery Management Checkups for Adults with Chronic Substance Use Disorders.” Journal of Substance Abuse Treatment, 41(2): 201−207, 2011.

ii. Lewis, J.E., Clark, J.D. 3rd, LeBlanc, W G., Fleming, L.E., Cabán−Martinez, A.J., Arheart, K.L., Tannenbaum, S.L., Ocasio, M.A., Davila, E.P., Kachan, D., McCollister, K.E., Dietz, N., Bandiera, F.C., Clarke, T.C., and Lee, D.J. “Cardiovascular Fitness Levels among American Workers.” Journal of Occupational and Environmental Medicine, 53(10): 1115−21, 2011.

jj. Caban−Martinez, A.J., Lee, D.J., Fleming, L.E., Arheart, K.L., LeBlanc, W.G., McCollister, K.E., Christ, S.L., Louie, G.H., Tancredi, D.J., and Muennig, P. “Arthritis, Occupational Class, and the Aging U.S. Workforce.” American Journal of Public Health, 101(9): 1729−34, 2011.

kk. Caban−Martinez, A.J., Davila, E.P., Lam, B.L., Dubovy, S.R., McCollister, K.E., Fleming, L.E., Zheng, D., and Lee, D.J. “Age−related Macular Degeneration and Smoking Cessation Advice by Eye Care Providers: A Pilot Study.” Preventing Chronic Disease, 8(6):A147, 2011.

ll. Dietz, N.A., Lee, D.J., Fleming, L.E., LeBlanc, W.G., McCollister, K.E., Arheart, K.L., Davila, E.P., and Caban−Martinez, A.J. “Trends in Smokeless Tobacco Use in the U.S. Workforce: 1987– 2005.” Tobacco Induced Diseases, 9:6 (1 June 2011).

mm. Caban−Martinez, A.J., Lee, D.J., Goodman, E., Davila, E.P., Fleming, L. E., LeBlanc, W.G, Arheart, K.L., McCollister, K.E., Christ, S.L., Zimmerman, F.J., Muntaner, C., and Hughes, D. “Health Indicators among Unemployed and Employed Young Adults.” Journal of Occupational & Environmental Medicine, 53(2):196−203, 2011.


8

nn. Pyne, J., Tripathi, S., French, M.T., McCollister, K.E., Rapp, R., and Booth, B. “Longitudinal Association of Preference−Weighted Health−Related Quality of Life Measures and Substance Use Disorder Outcomes.” Addiction, 106(3): 507−515, 2011.

oo. Zhang, S., Roberts, B., and McCollister, K.E. “Therapeutic Community in a California Prison: Treatment Outcomes after Five Years.” Crime and Delinquency, 57(1) 82–101, 2011.

pp. Davila, E.P., Florez, H., Fleming, L.E., Lee, D.J., Goodman, E., LeBlanc, W.G., Caban−Martinez, A.J., Arheart, K.L., McCollister, K.E., Christ, S.L., Clark, J.C., and Clarke, T. “Prevalence of the Metabolic Syndrome among U.S. Workers.” Diabetes Care, 33(11): 2390−2395, 2010.

qq. Davila, E.P., Lee, D.J., Fleming, L.E., LeBlanc, W.G., Arheart, K.L., Dietz, N., Lewis, J.E., McCollister, K.E., and Caban−Martinez, A.J. “Sleep Disorders and Secondhand Smoke Exposure in the U.S. Population.” Nicotine and Tobacco Research, 12: 294−299, 2010.

rr. Davila, E.P., Christ, S.L., Caban−Martinez, A.J., Lee, D.J., Arheart, K.L., LeBlanc, W.G., McCollister, K. E., Clarke, T., Zimmerman, F., Goodman, E., Muntaner, C., and Fleming, L.E. “Young Adults, Mortality, and Employment.” Journal of Occupational & Environmental Medicine, 52(5): 501−4, 2010.

ss. Caban−Martinez, A.J., Lee, D.J., Davila, E.P., LeBlanc, W.G., Arheart, K. L., McCollister, K.E., Christ, S. L., Clarke, T., and Fleming, L.E. “Sustained Low Influenza Vaccination Rates in US Healthcare Workers.” Preventive Medicine, 50(4): 210−2, 2010.

tt. McCollister, K.E., French, M.T., and Fang, H. “The Cost of Crime to Society: New Crime−Specific Estimates for Policy and Program Evaluation.” Drug and Alcohol Dependence, 108: 98–109, 2010.

uu. Bandiera, F.C., Arheart, K.L., Caban−Martinez, A.J., Fleming, L.E., McCollister, K.E., Dietz, N.A., LeBlanc, W.G., Davila, E.P., Lewis, J.E., Serdar, B., and Lee, D.J. “Second Hand Smoke Exposure and Depressive Symptoms.” Psychosomatic Medicine, 72: 68−72, 2010.

vv. Vidal, L., LeBlanc, W.G., McCollister, K.E., Arheart, K.L., Chung−Bridges, K., Christ, S., Caban−Martinez, A.J., Lewis, J. Lee, D.J., Clark III, J., Davila, E., and Fleming, L.E. “Cancer Screening in U.S. Workers.” American Journal of Public Health, 99: 59−65, 2009.

ww. McCollister, K.E., French, M.T., Sheidow, A., Henggeler, S.W., and Halliday−Boykins, C.A. “Estimating the Differential Costs of Criminal Activity for Juvenile Drug Court Participants: Challenges and Recommendations.” Journal of Behavioral Health Services and Research, 36(1): 111−126, 2009.

xx. Lee, D.J., Lam, B.L., Arora, S., Arheart, K.L., McCollister, K.E., Zheng, D.D., Christ, S.L., Davila, E.P. “Reported Eyecare Utilization among US Adults: The 1997−2005 National Health Interview Survey.” Archives of Ophthalmology, 127(3): 303−310, 2009.

yy. Davila, E.P., Caban−Martinez, A.J., Muennig, P., Lee, D.J., Fleming, L., Ferraro, K.F., LeBlanc, W.G., Lam, B., Arheart, K.L., McCollister, K.E., Zheng, D., and Christ, S.L. “Sensory Impairment in Older U.S. Workers.” American Journal of Public Health, 99(8): 1378−85, 2009.

zz. Lee, D.J., Arheart, K.L., Lam, B.L., Zheng, D.D., Christ, S.L., McCollister, K.E., and Davila, E.P. “Trends in Reported Visual Impairment in United States Adults.”


9

Ophthalmic Epidemiology, 16(1): 42−9, 2009.


10

aaa. McCollister, K.E., Arheart, K., Lee, D., Fleming, L.E., Chung−Bridges, K., Christ, S.L., LeBlanc, W., Caban−Martinez, A.J., and Davila, E. “Declining Health Insurance Coverage Among US Workers: Not All Jobs Are Created Equal.” American Journal of Industrial Medicine, 53(2): 163−70, 2009.

bbb. Zhang, S., Roberts, B., and McCollister, K.E. “An Economic Analysis of the In−prison Therapeutic Community Model on Prison Management Costs.” Journal of Criminal Justice, 37: 388–395, 2009.

ccc. McCollister, K.E., French, M.T., Pyne, J., Booth, B., Rapp, R., and Carr, C. “The Cost of Treating Addiction from the Client’s Perspective: Results from a Multi−Modality Application of the Client DATCAP.” Drug and Alcohol Dependence, 104(3): 241−8, 2009.

ddd. Lewis, J.E., Arheart, K.L., LeBlanc, W.G., Fleming, L.E., Lee, D.J., Davila, E.P., Caban−Martinez, A.J., Dietz, N.A., McCollister, K.E., Bandiera, F.C., and Clark, J.D. Jr. “Food Label Use and Awareness of Nutritional Information and Recommendations among Persons with Chronic Disease.” American Journal of Clinical Nutrition, 90(5): 1351−7, 2009.

eee. French, M.T., Zavala, S.K., McCollister, K.E., Waldron, H., Turner, C., and Ozechowski, T. “Cost−Effectiveness Analysis (CEA) of Four Interventions for Adolescents with a Substance Use Disorder.” Journal of Substance Abuse Treatment, 34(3): 272−81, 2008.

fff. Pyne, J.M., French, M.T., McCollister, K.E., Tripathi, S., Rapp, R., and Booth, B. “Preference−Weighted Health−Related Quality of Life Measures and Substance Use Disorder Severity.” Addiction, 103(8): 1320−1329, 2008.

ggg. Chung−Bridges, K., Muntaner, C., Fleming, L.E., Lee, D.J., Arheart, K.L., LeBlanc, W.G., Christ, S.L., McCollister, K.E., Caban−Martinez, A.J., and Davila, E. “Occupational Segregation as a Determinant of Worker Health.” American Journal of Industrial Medicine, 51: 555−567, 2008.

hhh. Arheart, K.L., Lee, D.J., Fleming, L.E., LeBlanc, W.G., Dietz, N.A., McCollister, K.E., Wilkinson, J.D., Lewis, J.E., Clark, J.D., Davila, E.P., and Bandiera, F.C. “Accuracy of Self−reported Smoking and Secondhand Smoke Exposure in the US Workforce: the National Health and Nutrition Examination Surveys.” Journal of Occupational and Environmental Medicine, 50(12): 1414−20, 2008.

iii. LeBlanc, W.G., Vidal, L., Kirsner, R.S., Lee, D.J., Caban−Martinez, A.J., McCollister, K.E., Arheart, K.L., Chung−Bridges, K., Christ, S.L., Clark, J., Lewis, J.E., Davila, E.P., Rouhani, P., and Fleming, L.E. “Reported Skin Cancer Screening of U.S. Adult Workers.” Journal of the American Academy of Dermatology, 59(1): 55−63, 2008.

jjj. Fleming, L.E., Lee, D.J., Caban−Martinez, A.J., LeBlanc, W.G., McCollister, K.E., Bridges Chung, K., Christ, S.L., Arheart, K.L., and Pitman, T. “The Health Behaviors of the Older US Worker.” American Journal of Industrial Medicine, 50: 427−437, 2007.

kkk. Lee, D.J., Fleming, L.E., Arheart, K.L., LeBlanc, W.G., Caban−Martinez, A.J., Chung Bridges, K., Christ, S.L., McCollister, K.E., and Pitman, T. “Smoking Rate Trends in US Occupational Groups: The 1987−2004 National Health Interview Survey (NHIS).” Journal of Occupational and Environmental Medicine, Vol. 49 (1): 75 – 81, 2007.

lll. Caban−Martinez, A.J., Lee, D.J., Fleming, L.E., LeBlanc, W.G., Arheart, K.L., Chung−Bridges, K., Christ, S.L., McCollister, K.E., and Pitman, T. “Leisure−Time Physical Activity Levels of the U.S. Workforce.” Preventive Medicine, 44: 432−436, 2007.

mmm. Lee, D.J., Fleming, L.E., McCollister, K.E., Caban−Martinez, A.J., Arheart,


11

K.L., LeBlanc, W.G., Chung−Bridges, K., Christ, S.L., Dietz, N., and Clark, JD. “Healthcare


12

Provider Smoking Cessation Advice among US Worker Groups.” Tobacco Control, 16: 325−328, 2007.

nnn. Christ, S.L., Lee, D., Fleming, L.E., LeBlanc, W., Arheart, K., Chung−Bridges, K., Caban−Martinez, A.J., and McCollister, K.E. “Employment and Occupation Effects on Depressive Symptoms in Older Americans: Does Working Past Age 65 Protect Against Depression?” Journal of Gerontology: Social Sciences, 62(6): S399−403, 2007.

ooo. *§Karayalcin, A.C., and McCollister, K.E. “Income Distribution, Sovereign Debt, and Public Investment.” Economics and Politics, 17(3): 351−365, 2005.

ppp. French, M.T., McCollister, K.E., Alexandre, P.K., Chitwood, D., and McCoy, C.B. “Revolving Roles in Drug−Related Crime: The Cost of Chronic Drug Users as Victims and Perpetrators.” Journal of Quantitative Criminology, 20(3): 217−241, 2004.

qqq. Logan, T., Hoyt, W., McCollister, K.E.., French, M., Leukefeld, C., and Minton, L. “Economic Evaluation of Drug Court: Methodology, Results, and Policy Implications.” Evaluation and Program Planning, 27(4): 381−396, 2004.

rrr. McCollister, K.E., French, M.T., Prendergast, M.L., Hall, E. and Sacks, S. “Long−Term Cost−Effectiveness of Addiction Treatment for Criminal Offenders: Evaluating Treatment History and Reincarceration Five Years Post−Parole.” Justice Quarterly, 21(3): 659−679, 2004.

sss. McCollister, K.E., French, M.T., Prendergast, M., Wexler, H., Sacks, S., and Hall, E. “Is In−Prison Treatment Enough? A Cost−Effectiveness Analysis of Prison−Based Treatment and Aftercare Services for Substance Abusing Offenders.” Law and Policy, 25 (1): 62−83, 2003.

ttt. McCollister, K.E., and French, M.T. “The Relative Contribution of Outcome Domains in the Total Economic Benefit of Addiction Interventions: A Review of First Findings.” Addiction, 98: 1647−1659, 2003.

uuu. McCollister, K.E., French, M.T., Inciardi, J.A., Butzin, C.A., Martin, S.S., and Hooper, R.M. “Post−Release Substance Abuse Treatment for Criminal Offenders: A Cost−Effectiveness Analysis.” Journal of Quantitative Criminology, 19(4): 389−407, 2003.

vvv. French, M.T., McCollister, K.E., Sacks, S., McKendrik, K., and De Leon, G. “Benefit−Cost Analysis of a Modified Therapeutic Community for Mentally Ill Chemical Abusers.” Evaluation and Program Planning, 25(2): 137−148, 2002.

www. French, M.T., McCollister, K.E., Cacciola, J., Durell, J., and Stephens, R. L. “Benefit−Cost Analysis of Addiction Treatment in Arkansas: Specialty and Standard Residential Programs for Pregnant and Parenting Women.” Substance Abuse, 23(1): 31−51, 2002.

xxx. Burbano, X., Miguez−Burbano, M.J., McCollister, K.E., Zhang, G., Rodriguez, A., Ruiz, P., Lecusay, R., and Shor−Posner, G. “Impact of Selenium Chemoprevention Clinical Trial on Hospital Admissions of HIV Infected Participants.” HIV Clinical Trials Journal, 3(6): 483−91, 2002.

yyy. *§Karayalcin, A.C., McCollister, K.E., and Mitra, D. “Infrastructure, Returns to Scale, and Sovereign Debt.” Journal of International Trade and Economic Development, 11 (3): 267−279, 2002.

17. Other works, publications, abstracts:


13

1. McCollister, K.E. “Cost Effectiveness of Substance Abuse Treatment in Criminal Justice Settings.” Knowledge Asset Web site created by the Robert Wood Johnson Foundation's Substance Abuse Policy Research Program; July 2008. http://saprp.org/knowledgeassets/knowledge_detail.cfm?KAID=10

2. McCollister, K.E. “Estimating Victim Costs of Crime for Cost−benefit Analyses in Criminal Justice.” VERA Institute for Justice. Cost−benefit Knowledge Bank Webinar on Demystifying Crime Victim Costs (with T. Stanford and V. Levshin). VERA Victim Costs Webinar

3. McCollister, K.E., Baumer, P., and the University of Arizona - Southwest Institute for Research on Women (2015). Cross-Site Report: Cost Analysis Overview and Results Narrative – March 2015. The University of Arizona: Tucson, Arizona.

18. Other Works, Invited Revise/Resubmit or Accepted for Publication

The OUD Modeling Group (includes McCollister, K.E.). “How simulation modeling can support the public health response to the opioid crisis in North America: setting priorities and assessing value.” Invited Revise & Resubmit at International Journal of Drug Policy.

Onuoha E.O., Leff J.A., Schackman B.R., McCollister K.E., Polsky D., Murphy S.M. Recent Economic Evaluations of Pharmacological Treatment for Opioid Use Disorder: A Systematic Literature Review. Invited Revise & Resubmit at Value in Health.

V. PROFESSIONAL

19. Funded Research

KENTUCKY CAN (Communities and Networks) HEAL (Helping End Addiction Long-term) Principal Investigator: Sharon Walsh, PhD (University of Kentucky) Role: Principal Investigator of Subcontract and Health

Economics Lead for Kentucky (20%) Grant # UM1DA049406 Funding Source: National Institute on Drug Abuse Project Period: 07/01/19-06/30/2023 Total Award: $77,741 (direct)

HEALING COMMUNITIES STUDY: DATA COORDINATING CENTER Principal Investigator: Richard Williams, PhD

Role: Principal Investigator of Subcontract and Health Economics Representative for Kentucky (10%)

Grant # Funding Source: National Institute on Drug Abuse Project Period: 07/01/19 – 06/30/23 Total Award: $23,777 (direct)

ORGANIZATIONAL AND ENVIRONMENTAL FACTORS INFLUENCING IMPLEMENTATION OF EVIDENCE-BASED PRACTICES IN JUVENILE JUSTICE SETTINGS

http://saprp.org/knowledgeassets/knowledge_detail.cfm?KAID=10http://www.slideshare.net/CBKBank/110721-victim-costs-webinar-final-9595708http://www.slideshare.net/CBKBank/110721-victim-costs-webinar-final-9595708http://www.slideshare.net/CBKBank/110721-victim-costs-webinar-final-9595708


14

Principal Investigator: Kathryn E. McCollister, PhD Role: Principal Investigator (20%) Grant # R21DA044378 Funding Source: National Institute on Drug Abuse Project Period: 07/01/17 – 06/30/20 Total Award: $430,591

CHERISH: CENTER FOR HEALTH ECONOMICS OF TREATMENT INTERVENTIONS FOR SUBSTANCE USE DISORDER, HCV, AND HIV Principal Investigator: Bruce R. Schackman, PhD, MBA Role: Principal Investigator of Subcontract and Co-Director of the

Methodology Core (20%) Grant # P30DA040500 Funding Source: National Institute on Drug Abuse Project Period: 07/01/15 – 04/30/20 Total Award: $288,827

EVALUATION OF LIFE-STEPS TO ENHANCE ADHERENCE AND ENGAGEMENT IN PREP CARE Principal Investigator: Steven Safren, PhD Role: Co-Investigator and Health Economics Lead (15%) Grant #: MH118043 Funding Source: National Institute on Mental Health Project Period: 07/15/19-04/30/24

Total Award:

EVALUATING THE EFFECTIVENESS OF AN eHEALTH EVIDENCE BASED INTERVENTION FOR LATINO YOUTH IN PRIMARY CARE Principal Investigator: Guillermo (Willy) Prado, PhD Role: Co-Investigator (20%) Grant # R01 DA040756 Funding Source: National Institute on Drug Abuse Project Period: July 1, 2016 – April 30, 2021 Total Award: $795,348

MYTPILL: A NOVEL STRATEGY TO MONITOR ANTIRETROVIRAL ADHERENCE AMONG HIV+ PRESCRIPTION OPIOID USERS Principal Investigator: Boyer, PhD Role: Co-Investigator on subcontract to Dr. Carrico (10%) Grant # R01DA047236 Funding Source: National Institute on Drug Abuse Project Period: 06/01/19 – 04/30/23 Total Award: $170,692

MASSACHUSETTS JUSTICE COMMUNITY OPIOID INNOVATION NETWORK (JCOIN), CLINICAL RESEARCH CENTER Principal Investigator: Peter Friedmann, Ph.D. and Liz Evans, Ph.D. Role: Principal Investigator of subcontract and co-lead of health

economic analysis (10%) Grant #: UG1DA050067 Funding Source: National Institute on Drug Abuse


15

Project Period: 07/15/19-04/30/24 Total Award: $47,181 (direct)

IMPROVING RETENTION ACROSS THE OUD SERVICE CASCADE UPON REENTRY FROM JAIL USING RECOVERY MANAGEMENT CHECKUPS Principal Investigator: Christy K. Scott, PhD Role: Principal Investigator of Subcontract and Health Economics Lead

(15%) Grant #: UG1DA050065 Funding Source: National Institute on Drug Abuse Project Period: 07/15/19-04/30/24 Total Award: $64,533 (direct)

KENTUCKY WOMEN’S JUSTICE COMMUNITY OPIOID INNOVATION NETWORK (W- JCOIN) CLINICAL RESEARCH CENTER Principal Investigator: Michele Staton, PhD Role: Principal Investigator of Subcontract and Health Economics Lead

(15%) Grant #: UG1DA050069 Funding Source: National Institute on Drug Abuse Project Period: 07/15/19-04/30/24 Total Award: $73,075 (direct)

TRANSITIONS CLINIC NETWORK: POST INCARCERATION ADDICTION TREATMENT, HEALTHCARE, AND SOCIAL SUPPORT (TCN PATHS) STUDY Principal Investigator: Emily Wang, PhD Role: Principal Investigator of Subcontract and Health Economics Lead

(15%) Grant #: UG1DA050062 Funding Source: National Institute on Drug Abuse Project Period: 07/15/19-04/30/24

Total Award: $71,911 (direct)

PREVENTING OPIOID USE AMONG JUSTICE-INVOLVED YOUTH AS THEY TRANSITION TO ADULTHOOD: LEVERAGING SAFE ADULTS (LeSA) Principal Investigator: Danica K. Knight, PhD Role: Principal Investigator of Subcontract and Health Economics Lead

(3%) Grant #: UG3DA050250 Funding Source: National Institute on Drug Abuse Project Period: 12/1/2019 – 11/30-2024

Total Award: $26,368 (direct)

Completed:

LEVERAGING UNTAPPED OPPORTUNITIES IN PLACE AND TIME: A COMMUNITY-

BASED CHILD WELL-BEING COLLABORATIVE [Phase 2019 Project for the University of Miami Laboratory for Integrative Knowledge (U-LINK)] Principal Investigator: Rebecca B. Shearer, PhD Role: Team Member (5%) Grant # U-LINK 19-781


16

Funding Source: University of Miami Project Period: 01/02/2019 – 08/31/2019

Total Award: $40,000

KIIDS – KNOWING ABOUT INTERVENTION IMPLEMENTATION IN DETENTION SITES Principal Investigator: R. DiClemente, PhD Role: Principal Investigator on Subcontract (10%) Grant # 5U01DA036233-02 Funding Source: National Institute on Drug Abuse Project Period: 07/01/2013 – 06/30/2018 Total Award: $433,508

JJ-TRIALS: THE JUVENILE JUSTICE TRANSLATIONAL RESEARCH ON ADOLESCENTS IN THE LEGAL SYSTEM COST ANALYSIS PROTOCOL SUPPLEMENT Principal Investigator: Kathryn McCollister Role: Principal Investigator on Supplement from Emory

University (20%) Grant # U01DA036233 Funding Source: National Institute on Drug Abuse Project Period: 07/01/15 – 06/30/16

Total Award: $ 151,965

ECONOMIC EVALUATION OF RECOVERY MANAGEMENT CHECKUPS FOR WOMEN OFFENDERS (RMC−WO) Principal Investigator: Kathryn E. McCollister, PhD Role: Principal Investigator (30%) Grant # R01 DA031785 Funding Source: National Institute on Drug Abuse Project Period: 07/2011 – 07/2015 Total Award: $1,104,340

FAMILY INTERVENTION FOR TEEN DRINKING AND ALCOHOL−RELATED CRISES IN THE ER Principal Investigator: Cynthia Rowe, PhD Role: Investigator (10%) Grant # 1R01AA016186 Funding Source: National Institute on Alcohol Abuse and Alcoholism Project Period: 05/01/2010 – 04/30/2015 Total Award: $3,020,544

FAMILIAS UNIDAS STAGE III STUDY: PREVENTING SUBSTANCE USE IN HISPANIC YOUTH Principal Investigator: Guillermo Prado, PhD Role: Collaborator (10%) Grant # 1R01DA025192 Funding Source: National Institute on Drug Abuse Project Period: 12/05/2008 – 11/30/2014 Total Award: $3,291,964


17

INNOVATIONS FOR MEDICAID SCHOOL CHILDREN AND THEIR PARENTS IN FLORIDA Principal Investigator: Jocelyn Lawrence, M.D. Role: Health Economist/Collaborator (20%) Grant # CMS−1C1−331028 Funding Source: Centers for Medicare and Medicaid Services Project Period: 06/2012 – 05/2015 Total Award:

SURVEILLANCE OF MORTALITY AND MORBIDITY IN US WORKERS Principal Investigator: David Lee, PhD Role: Investigator (10%) Grant # R01 OH003915 Funding Source: National Institute for Occupational Safety and Health Project Period: 9/2006 – 8/2013

Total Award: $1,223,841

PREVENTING DRUG ABUSE AND HIV IN HISPANIC FIRST OFFENDERS Principal Investigator: Guillermo Prado, PhD Role: Investigator (10%) Grant # R01 DA025894 Funding Source: National Institute on Drug Abuse Project Period: 06/2009 – 05/2013 Total Award: $650,633

HEALTHY CAREGIVERS; HEALTHY CHILDREN Principal Investigator: R. Natale; S. Messiah; L. Sanders; A. Delamater Role: Investigator (10% in year 3) Grant # 2009−05065 Funding Source: U.S. Department of Agriculture Project Period: 04/2010 – 03/2013 Total Award: $1,000,000

HEALTH AND ECONOMIC ASPECTS OF OCULAR DISEASE IN THE U.S. Principal Investigator: David Lee, PhD Role: Investigator (7%) Grant # R21 EY019096 Funding Source: National Eye Institute Project Period: 09/2010 – 08/2012 Total Award: $191,252

PROJECT STRIDE: MULTISITE ECONOMIC COST ANALYSIS OF CTN PROTOCOL 0037 Principal Investigator: Kathryn McCollister, PhD (PI of FL Node: Jose

Szapocznik) Role: PI of Ancillary Study (30%) Grant # U10 DA13720 Funding Source: National Institute on Drug Abuse Project Period: 05/2011 – 08/2011

Total Award: $ 108,763


18

LONG−TERM OUTCOMES AND ECONOMIC IMPACT OF THE DETENTION TO COMMUNITY MODEL Principal Investigator: Cynthia Rowe, Ph.D. Role: Co−Investigator (5%) Grant #: 1R01 DA026126 Funding Source: National Institute on Drug Abuse Project Period: 09/2009 – 08/2011

Total Award: $1,075,678

ECONOMIC EVALUATION METHODS: DEVELOPMENT AND APPLICATIONS Principal Investigator: Michael French, Ph.D. Role: Investigator (10%) Grant # R01 DA018645 Funding Source: National Institute on Drug Abuse/NIH Project Period: 05/2005 to 04/2012 Total Award: $3,161,675

MORTALITY AND HEALTH DISPARITIES OF THE NEW NIOSH NORA AGENDA Principal Investigator: David Lee, Ph.D. Role: Investigator (10%) Grant # 211−2008−26814 Funding Source: NIOSH/CDC Project Period: 07/2008 – 06/2010


ECONOMIC EVALUATION OF SUBSTANCE ABUSE TREATMENT IN CRIMINAL JUSTICE SETTINGS Principal Investigator: Kathryn E. McCollister, Ph.D. Role: Principal Investigator Grant #: K01 DA013962 Funding Source: National Institute on Drug Abuse Project Period: 04/2004 to 05/2009 Total Award: $595,836

EPIDEMIOLOGY OF VISUAL IMPAIRMENT: THE 1986−2002 NHIS Principal Investigator: David Lee, Ph.D. Role: Investigator Grant # 1R03 EY016481 Funding Source: National Eye Institute Project Period: 09/2006 – 08/2008


REDUCING THE BURDEN OF TOBACCO−RELATED CANCERS IN FLORIDA Principal Investigator: David Lee, Ph.D. Role: Investigator Grant #: 06TSP−03 Funding Source: James and Esther King Biomedical Research Program

Project Period: 07/2006 to 06/2008 Total Award: $999,973


19

BENEFIT−COST ANALYSIS OF THE CALIFORNIA SUBSTANCE ABUSE TREATMENT FACILITY (CSATF) Principal Investigator: Sheldon Zhang, Ph.D. Role: Co−Principal Investigator Grant #: CFDA C03.503 Funding Source: Department of Corrections, State of California Project Period: 7/2003 to 6/2006


WOMEN’S PRISON TC: OUTCOME, PROCESS, AND ECONOMIC ANALYSIS Principal Investigator: JoAnn Sacks, Ph.D. Role: Senior Research Investigator Grant #: unknown Funding Source: National Institute on Drug Abuse Project Period: 10/2001 to 9/2006 Total Award: $487,311

ECONOMIC COSTS AND BENEFITS OF ALCOHOL SERVICES AND INTERVENTIONS Principal Investigator: Michael French, Ph.D. Role: Project Director Grant #: R01 AA13167 Funding Source: National Institute on Alcohol Abuse and Alcoholism Project Period: 4/2001 to 3/2006 Total Award: $2,640,929

COSTS AND BENEFITS OF PRISON−BASED TREATMENT PLUS AFTERCARE FOR DRUG ABUSING OFFENDERS Principal Investigator: Kathryn E. McCollister, PhD Role: Principal Investigator Grant # 041070 Funding Source: The Robert Wood Johnson Foundation Substance Abuse

Policy Research Program (SAPRP) Project Period: 12/2000 – 11/2004 Total Award: $189,133

20. Editorial responsibilities:

Member of editorial board Journal of Substance Abuse Treatment 2012−Present

Member of editorial board PLOS One 2019 – Present

Member of editorial board International Journal of Excellence in

Healthcare Management

2018 - Present

Manuscript referee for:

Health Affairs 2016-Present

JAMA 2017-Present

Journal of Mental Health Policy and Economics 2004−Present

Crime and Delinquency 2011−Present

Health Economics 2008−Present


20

Criminal Justice Policy Review 2011−Present

Drug and Alcohol Dependence 2008−Present

Addiction 2003−Present

Evaluation and Program Planning 2002−Present

Alcohol Research and Health 2002−Present

Justice Quarterly 2003−Present

Journal of Psychoactive Drugs 2002−Present

Journal of Substance Abuse Treatment 2002−Present

Journal of Behavioral Health Services & Research 2008–Present

Journal of Offender Rehabilitation 2013−Present

Value in Health 2013−Present

21. Professional and Honorary Organizations:

Member of:

Delta Omega Honorary Society in Public Health (Beta Sigma Chapter) 2010–Present

American Society of Health Economists 2006−Present

International Health Economics Association 2000−Present

American Economic Association 2000−Present

American Public Health Association 2000−Present

22. Honors and Awards:

Graduate fee grant for academic achievement, State of Florida 1997−1999

Graduate assistantship, Department of Economics, 1995−1999 Florida International University

23. Post−Doctoral Fellowships: N/A

24. Other Professional Activities:

Grant Reviews:

National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) 2012-present Ad−Hoc Reviewer

National Institutes of Health (NIH), National Institute on Minority Health and Health 2017 Disparities (NIMHD), Ad-Hoc Reviewer

National Institutes of Health (NIH), National Eye Institute (NEI) 2005, 2012 Ad−Hoc Reviewer

Robert Wood Johnson Foundation, Substance Abuse Policy Research Program 2000 – 2005


21

Ad−Hoc Reviewer

Centers for Disease Control and Prevention, Mentored Public Health Research 2007 Scientist Development Award (K01); Ad−Hoc Reviewer

Invited Workshops and Trainings

1. “Introduction to Economic Evaluation.” Pre-conference workshop, National Drug Abuse

Treatment Clinical Trials Network (CTN) Annual Steering Committee Meeting, March 22, 2020.

2. “Understanding the Economic Impact of Multisite and Multisystem Interventions.” Co- presenters Kathryn E. McCollister, PhD and Sean M. Murphy, PhD. Addiction Health Services Research Annual Meeting Pre-Congress Workshop. October 16, 2019.

3. Expanding The Impact Of Substance Use Disorder Research: Economic Analysis For Program And Policy Evaluation. Co-presenters Kathryn E. McCollister, PhD and Sean M. Murphy, PhD. College on Problems of Drug Dependence (CPDD) Conference Workshop. June 18, 2019.

4. Expanding The Impact Of Substance Use Disorder Research: Economic Analysis For Program And Policy Evaluation. Co-presenters Kathryn E. McCollister, PhD and Sean M. Murphy, PhD. Addiction Health Services Research Annual Meeting Pre-Congress Workshop. October 17, 2018.

5. An Introduction to Economic Evaluation in Substance Use Disorder Research. Pre- conference workshop. Co-presenters Kathryn E. McCollister, PhD and Sean M. Murphy, PhD. National Drug Abuse Treatment Clinical Trials Network (CTN) Annual Steering Committee Meeting. March 19, 2018.

6. New Insights Into the Economics of Substance Use Disorder Treatment: Addressing the Opioid Epidemic. Pre-Congress Half-Day Workshop at the International Health Economics Association World Congress. Boston, Massachusetts, July 8-11, 2017.

Invited Presentations

National and International Conferences:

"Implementation of evidence based practices for substance use disorders in juvenile justice settings: Evaluating costs across implementation phases." Symposium presentation, Academy Health 12th Annual Conference on the Science of Dissemination and Implementation, Arlington, VA, December 4, 2019.

“Economic Analysis of Implementing Evidence Based Practices in Juvenile Justice Settings:

Resource Utilization and Budget Impact Across Implementation Phases.” Symposium presentation, Addiction Health Services Research Annual Meeting, Park City, Utah, October 16 – 18, 2019

“Health Services Data Harmonization for Economic Evaluation of Substance Use Disorder Treatment and Policy.” Poster presentation, Addiction Health Services Research Annual Meeting, Savannah, Georgia, October 17 – 19, 2018.


22

“Organizational and Environmental Factors Influencing Implementation of Evidence-based Practices in Juvenile Justice Settings.” Poster presentation, European Health Economics Association (EuHEA), Biennial Conference. Maastricht, Netherlands, July 11- 14, 2018.

“Cost Analysis of Implementing Evidence Based Practices in Juvenile Justice Settings: Results From A Multisite Randomized Trial.” Poster presentation, European Health Economics Association (EuHEA), Biennial Conference. Maastricht, Netherlands, July 11- 14, 2018.

“Resources and associated costs of implementing pharmacotherapy for opioid dependence initiated in inpatient detoxification settings: Results from a multisite randomized clinical trial.” Poster presentation at College on Problems of Drug Dependence Annual Meeting, San Diego, California, June 10-14, 2018.

“Economic Data Harmonization for Substance Use Disorder Research: Criminal Justice Measures.” Symposium presentation, Addiction Health Services Research Annual Meeting. Madison, Wisconsin, October 18-20, 2017.

“New Insights Into the Economics of Substance Use Disorder Treatment: Addressing the Opioid Epidemic.” Pre-Congress Half-Day Workshop at the International Health Economics Association World Congress. Boston, Massachusetts, July 8-11, 2017.

“Resources and associated costs of implementing medication assisted treatment for opioid dependence in inpatient detoxification settings: Preliminary findings from a multisite randomized clinical trial.” Symposium presentation, International Health Economics Association World Congress. Boston, Massachusetts, July 8-11, 2017.

“Economic Consequences of Substance Use Disorders, HCV, and HIV: Monetary Conversion Factors for Program and Policy Evaluation.” Symposium presentation, Addiction Health Services Research Annual Meeting. Seattle, Washington, October 13-15, 2016.

“Estimating the Economic Consequences of Substance Use Disorders: Monetary Conversion Factors for Program and Policy Evaluation.” Symposium presentation, European Health Economics Association Biennial Conference. University of Hamburg, Hamburg, Germany. July 13 – 16, 2016.

“Economic Analysis of Implementing Evidence-Based Practices for Substance Use Disorders in Juvenile Justice Settings.” Poster presentation, European Health Economics Association Biennial Conference. University of Hamburg, Hamburg, Germany. July 13 – 16, 2016.

“Economic Evaluation of the Juvenile Drug Court Reclaiming Futures (JDCRF) Model.” Presented at the Addiction Health Services Annual Research Conference, Marina del Rey, California, October 16, 2015.

“Cost-Effectiveness Analysis of a Continuing Care Intervention for Cocaine Dependent Adults.” Presented at the International Health Economics Association World Congress, Milan, Italy, July 15, 2015.

“Economic Analysis of Recovery Management Checkups for Women Offenders (RMC-WO).” Presented at the Addiction Health Services Research Annual Meeting, Boston, MA, October 16, 2014.


23

“Longitudinal Analyses of the Societal Costs of Criminal Activity in an Aging Cohort of Minority Baby Boomers.” Presented at the International Health Economics Association and European Conference on Health Economics Joint Congress, Dublin, Ireland, July 14, 2014.

“The Economic Burden of Disease by Industrial Sector: Differences in Quality-Adjusted Life Years and Associated Costs.” Poster presentation at the 2013 American Public Health Association (APHA) Annual Meeting, Boston, Massachusetts, November 3, 2013.

“Informal Work and Problem Behavior among Middle School and High School Students.” Presented at the Addiction Health Services Research Annual Research Conference, Portland, Oregon, October 24, 2013.

“Work Experience and Sexual Behavior among Adolescents.” Presented at the International Health Economics Association (iHEA) World Congress, Sydney, Australia, July 9, 2013.

“The Economic Consequences of Substance Use Disorders: Monetary Conversion Factors for Economic Evaluation and Policy Analysis.” Presented at the Addiction Health Services Research Conference, New York, October 2012.

“Cost−effectiveness Analysis of a Family−based Drug Use and HIV Preventive Intervention Targeting Hispanic Juvenile, Offenders.” Presented at the Addiction Health Services Research Conference, New York, October 2012.

“Cost−effectiveness Analysis of Recovery Management Checkups for Adults with Substance Use Disorders.” Presented at the Addiction Health Services Research Conference, New York, October 2012.

“Economic Analyses of Recovery Management Checkups (RMCs) for Substance Use Disorders.” Presented at the Western Economic Association International (WEAI) Annual Meeting, San Francisco, California, June 30, 2012.

“Cost−Effectiveness Analysis of Recovery Management Checkups (RMCs) for Adults with Substance Use Disorders.” Presented at the 4th Biennial Conference of the American Society of Health Economists (ASHEcon), Minneapolis, Minnesota, June 11, 2012.

“Informal Work and Sexual Behavior among Young Adults.” Poster presentation at the 2011 American Public Health Association Annual Meeting, Washington, DC, October 30, 2011.

“Main Findings from the Florida Cost Analysis of Addiction Programs (FCAAP).” Presented at the Addiction Health Services Research Annual Meeting, Fairfax, Virginia. October 5, 2011.

“Demand for Substance Abuse Treatment among Low−Income Adults: Price Sensitivity and Other Barriers.” Poster presentation at the 2011 International Health Economics Association World Congress, Toronto, Ontario (Canada), July 10, 2011.

“Price−Elasticity of Demand for Substance Abuse Treatment among a Sample of Low−Income Adults.” Presented at the Addiction Health Services Research Annual Meeting, Lexington, KY, October 27, 2010.

“Informal Work, Substance Use, and Delinquency among Young Adults.” Poster presentation at the Addiction Health Services Research Annual Meeting, Lexington, KY, October 26, 2010.

“Estimating the Economic Cost of Underage Drinking in Florida.” Presented at the Addiction Health Services Research Annual Meeting in Boston, MA, October 22, 2008.


24

“The Cost of Addiction Treatment from the Client’s Perspective: Results from the Client Drug Abuse Treatment Cost Analysis Program.” Presented at the Second Biennial Conference of the American Society of Health Economists (ASHE), Durham, NC, June 23, 2008.

“Estimating the Costs of Post−release Interventions for Criminal Offenders with Substance Use Disorder: Findings from Two CJ−DATS Studies.” Presented at the Addiction Health Services Research Annual Meeting, Athens, GA, October 17, 2007.

“New Perspectives in Estimating the Costs of Substance Abuse Treatment using the Drug Abuse Treatment Cost Analysis Program (DATCAP): The Client DATCAP and Caretaker DATCAP.” Presented at the 2007 International Health Economics Association World Congress, Copenhagen, Denmark, July 11, 2007.

“Estimating the Differential Costs of Criminal Activity among Juvenile Drug Court Participant Challenges and Recommendations.” Presented at the 2007 Joint Meeting on Adolescent Treatment Effectiveness (JMATE), Washington, D.C., April 26, 2007.

“The Cost of Addiction Treatment from the Client’s Perspective: Results from the Client Drug Abuse Treatment Cost Analysis Program (Client DATCAP).” Presented at the Addiction Health Services Research Annual Meeting in Little Rock, AR, October 25, 2006.

“Juvenile Drug Court and the Economic Costs Associated with Reduced Criminal Activity for Adolescent Substance Users.” Presented at the Addiction Health Services Research Annual Meeting, Little Rock, AR, October 25, 2006.

“Cost Utility in Drug Abuse Treatment Evaluation.” Discussant at the First Inaugural Conference of the American Society of Health Economists, Madison, WI, June 5, 2006.

“Estimating the Caretaker Costs of Adolescent Addiction Treatment: Introducing the Caretaker Drug Abuse Treatment Cost Analysis Program (Caretaker DATCAP).” Presented at the 2006 Joint Meeting on Adolescent Treatment Effectiveness, Baltimore, MD, March 27, 2006.

“Long−term Cost Effectiveness of Addiction Treatment for Criminal Offenders: Evaluating Treatment History and Reincarceration 5 Years Post−parole.” Presented at the American Public Health Association Annual Meeting in Washington, DC, November 9, 2004

“The Cost of Crime to Society: New Crime−Specific Estimates for Policy and Program Evaluation.” Presented at the Addiction Health Services Research Annual Meeting, Philadelphia, PA, October 7, 2004.

“Post−Release Substance Abuse Treatment for Criminal Offenders: A Cost−Effectiveness

Analysis.” Presented at the American Public Health Association Annual Meeting, Philadelphia, PA, November 12, 2002.

“Post−Release Substance Abuse Treatment for Criminal Offenders: A Cost−Effectiveness Analysis.” Presented at the Addiction Health Services Research Annual Meeting, Key Largo, FL, October 30 – November 1, 2002.


25

“Is In−Prison Treatment Enough? A Cost−Effectiveness Analysis of Prison−Based Treatment and Aftercare Services for Substance Abusing Offenders.” Presented at the American Public Health Administration Annual Meeting, Atlanta, GA, October 24, 2001.

“Re−examining the Social Cost of Drug−Related Crime: Chronic Drug Users as Perpetrators

and Victims.” Presented at the American Public Health Administration Annual Meeting, Boston, MA, November 13, 2000.

“Re−examining the Social Cost of Drug−Related Crime: Chronic Drug Users as Perpetrators and Victims.” Presented at the Western Economic Association Annual Conference, Vancouver, British Columbia, June 30, 2000.

“Benefit−Cost Analysis of a Modified Therapeutic Community for Mentally Ill Chemical Abusers.” Presented at the MISA: Multiple Disorders, Multiple Perspectives Conference, sponsored by MCP Hahnemann University, Philadelphia, PA, April 28−30, 1999.

Other invited presentations:

“Health Economic Research Supporting the U.S. Response to the Opioid Crisis: Defining Cost Effective Interventions and Implementation Strategies,” Virtual Grand Rounds, Prevention Science and Methodology Group (PSMG), November 19, 2019.

“Economics of Continuing Care for Substance Use Disorders.” Grand Rounds Presentation, Weill Cornell Medicine, September 19, 2017.

“Methods and Data Sources for Measuring Comprehensive Disease and Disability Burden Using HRQL Metrics.” Presented at the National Institute on Occupational Safety and Health Workshop on Measuring the Economic Burden of Disease and Disability among U.S. Workers. Washington, DC, June 21, 2012.

“Juvenile Drug Court and the Economic Costs Associated with Reduced Criminal Activity for Adolescent Substance Users.” Presented at the NIDA Annual Advisory Board Meeting for Grant No. R01 DA018645, Miami, FL, November 8, 2006.

“Methods and Challenges in Conducting Economic Evaluations of Drug Court Interventions.” Invited presentation at the NIDA Symposium on Drug Court and Other Problem Solving Courts: State of the Science, Bethesda, MD, September 12, 2006.

“Estimating the Cost of Crime to Society: New Crime Specific Estimates for Policy and Program Evaluation.” Presented at the NIAAA Advisory Board Annual Meeting, Grant No. R01 AA13167, Miami Beach, FL, April 7, 2005.

“Economic Evaluation of Substance Abuse Treatment in Criminal Justice Settings.” Presented at NIDA’s CJ−DATS Steering Committee Meeting, Bethesda, MD, April 4, 2005.

“Economic Evaluation of Addiction Treatment for Criminal Offenders: Review of Recent Cost−Effectiveness Analyses.” Presented at the Substance Abuse Treatment and Corrections: Prison−based Treatment and Aftercare Teleconference organized by the Robert Wood Johnson Foundation and the Office of State Legislatures, March 25, 2004.

“A Cost−Effectiveness Analysis of the Amity In−Prison TC and Vista Aftercare Programs, Preliminary Results.” Presented at the University of California, Los Angeles, Drug Abuse Research Center, February 6, 2001.


26

“Benefit−Cost Analysis of a Modified Therapeutic Community for Mentally Ill Chemical Abusers.” Presented at the Health Administration Program/Department of Epidemiology and Public Health Joint Seminar Series, University of Miami, Miami, FL, October 20, 1999.

“Economic Evaluation of Substance Abuse Programs in Criminal Justice Settings.” Presented at the Policy Advisory Committee Meeting for the Office of Substance Abuse Programs, California Department of Corrections, San Diego, CA, August 19−20, 1999.

“Modeling the Political Economy of Sovereign Debt.” Presented at the International/Development Economics Seminar Workshop Series at Florida International University, Miami, Florida, April 14, 1999.

“Benefit−Cost Analysis of a Modified Therapeutic Community for Mentally Ill Chemical Abusers.” Presented at the NIDA Advisory Board Meeting, Grant R01 DA11506, University of Miami, Miami, FL, April 8, 1999.


27

VI. TEACHING

25. Teaching Awards Received: N/A

26. Teaching Specialization

Teach two graduate health economics courses covering standard economic theory and principles as well as economic evaluation of behavioral health care interventions; cost- effectiveness, benefit-cost, and cost-utility analyses; and health-related quality of life. Course evaluations have been consistently very good (on average 4.6 out of 5.0 since 2002).

Courses Taught

Health Economics for Evaluation and Policy (EPH−650)

2002 –Present

University of Miami, Department of Public Health Sciences

Health Economics and Financing (MD/MPH program; EPH-655) University of Miami, Department of Public Health Sciences

2015 -Present

Microeconomic Theory (Undergraduate) Florida International University, Department of Economics

1995 – 1999

Economic Growth (Graduate lab) Florida International University, Department of Economics

1996 – 1998

Macroeconomic Theory (Graduate lab) Florida International University, Department of Economics

1996 – 1998

University of Miami Invited Guest Lectureships

Global Health and Global Justice (EPH 616) 2018-Present

Introduction to Disease Prevention and Health Promotions (EPH−614) 2011−2017

Health Policy (EPH-652) 2013-2017

Program Evaluation (EPH-644) 2014-2016

Introduction to Public Health (EPH 600) 2016-2017

Epidemiology of Drug Abuse (EPH−590) 2006 − 2010

27. Thesis and Dissertation Advisor/Post−doctoral Student Supervision

Doctor of Philosophy in Epidemiology

Tyler S. Bartholomew, Ph.D. ABD. “Title Pending.” Member of dissertation committee. Department of Public Health Sciences, University of Miami Miller School of Medicine (2019 – present).


28

Diane Zheng, M.S., Ph.D. “Health Disparities in Visually Impaired Adults with Multi-morbidity.” Member of dissertation committee. Department of Public Health Sciences, University of Miami Miller School of Medicine (2016 – 2019).

Claudia Uribe, M.D., Ph.D. “The Effects of Bariatric Surgery on Medication and Health Services Utilization among Members from a Large Health Benefits Company.” Member of dissertation committee. Department of Epidemiology and Public Health, University of Miami Miller School of Medicine (2009 to 2011).

Alberto Caban−Martinez, D.O., Ph.D., MPH. “Musculoskeletal Disorders and Health Behaviors among US Adults.” Member of dissertation committee. Department of Epidemiology and Public Health, University of Miami Miller School of Medicine (2008 to 2010).

Eddy Perez, M.D., Ph.D. “An Enhanced Ecological Model Population−Based Approach to Reduce Health Disparities and Achieve Equity, Solidarity, and Gender Sensitivity for the Population Living in Southwestern Bateyes of the Dominican Republic.” Member of dissertation committee. Department of Epidemiology and Public Health, University of Miami Miller School of Medicine (2007 to 2009).

Daniel Impoinvil, Ph.D. “Epidemiological and Economic Analysis of Larval Control for the Reduction of Human−vector Contact in Urban and Rural Kenya.” Member of dissertation committee. Department of Epidemiology and Public Health, University of Miami Miller School of Medicine (2004 to 2006).

Master of Public Health/Master of Science in Public Health

Derek M. Freitas, B.S., MSPH. “Informal and Formal Work Experience and Sexual Behavior among Adolescents: Results from a Nationally−Representative Survey.” Advisor and member of thesis committee for MSPH. Department of Epidemiology and Public Health, University of Miami Miller School of Medicine (2011 to 2012).

Kristen S. Laengle, MPH. “Prevalence of Overweight among Haitian Immigrant Children and Adolescents.” Advisor and member of thesis committee for MPH. Department of Epidemiology and Public Health, University of Miami Miller School of Medicine (2004 to 2006).

VII. SERVICE

28. Academic Service

Director, Division of Health Services Research and Policy, Department 2016 - Present of Public Health Sciences

Capstone advisor to MPH/MDMPH students 2014-Present

Faculty judge for the Eastern Atlantic Student Research Forum 2012–Present

Member of the University of Miami Faculty Senate, Constituency A 2011–2018

Member of the Graduate Faculty 2002–Present

Member of DPHS Admissions Committee for the MPH, MSPH 2012−2016


29

Member of the Prevention Science and Community Health PhD 2015 Admissions Committee

Member of the DPHS Recruitment Committee 2003–2011

Participant as Group Preceptor for the first year medical Students’ journal club –Epi−ID module 2004 –2008

Member of the DPHS Curriculum/Admissions Committee for the MPH, MSPH 2008 – 2009

Chairperson of the DPHS Admissions Committee for the MPH, MSPH, and Ph.D. programs 2004 – 2008

Member of the DPHS Graduate Executive Policy Committee 2004 – 2008

29. Professional Service

Provide content for professional webinars and podcasts:

1. “Cost Effectiveness of Substance Abuse Treatment in Criminal Justice Settings.” Knowledge Asset Web site created by the Robert Wood Johnson Foundation's Substance Abuse Policy Research Program; July 2008. http://saprp.org/knowledgeassets/knowledge_detail.cfm?KAID=10

2. “Estimating Victim Costs of Crime for Cost−benefit Analyses in Criminal Justice.” VERA Institute for Justice. Cost−benefit Knowledge Bank Webinar on Demystifying Crime Victim Costs (with T. Stanford and V. Levshin). 2012. VERA Victim Costs Webinar

3. “Economic Evaluation of The Juvenile Drug Court Reclaiming Futures Model.” University of Arizona, Southwest Institute for Research on Women (SIROW). 2016. https://arizona.hosted.panopto.com/Panopto/Pages/Viewer.aspx?id=525d2c2b-5680-46c2- b179-800cfbe41bd9

Serve on panels at professional conferences as the expert in economic evaluation of addiction treatment and related interventions:

1. “Economic Evaluation of SBIRT: Understanding the Return on Investment Using Cost- Effectiveness and Benefit-Cost Analyses.” Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, the Screening, Brief Intervention, and Referral to Treatment (SBIRT), Virtual Grantee Meeting, 2014.

2. “Benefit-Cost Analysis of Juvenile Drug Court Reclaiming Futures: Results from Five Sites.”

Presented as part of an expert panel on the JDC/RF model at the Reclaiming Futures Annual Conference, hosted by the Robert Wood Johnson Foundation and the JDC/RF National Program Office. April 2016.

30. Community Service

Member of the Hollywood Lakes Civic Association 2016 – Present

http://saprp.org/knowledgeassets/knowledge_detail.cfm?KAID=10http://www.slideshare.net/CBKBank/110721-victim-costs-webinar-final-9595708https://arizona.hosted.panopto.com/Panopto/Pages/Viewer.aspx?id=525d2c2b-5680-46c2-b179-800cfbe41bd9https://arizona.hosted.panopto.com/Panopto/Pages/Viewer.aspx?id=525d2c2b-5680-46c2-b179-800cfbe41bd9https://arizona.hosted.panopto.com/Panopto/Pages/Viewer.aspx?id=525d2c2b-5680-46c2-b179-800cfbe41bd9


30

Member of the American Civil Liberties Union (ACLU) 2017 – 2018

kathryn e. mccollister, phd · 2 days ago · kathryn e. mccollister, phd 1 university of miami...

Documents